We are live on ! Find out more
STXS icon

Stereotaxis

4 hedge funds and large institutions have $982K invested in Stereotaxis in 2016 Q4 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, 1 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

20% less funds holding

Funds holding: 54 (-1)

26% less capital invested

Capital invested by funds: $1.34M → $982K (-$354K)

50% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 2

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 1

Holders
4
Holders Change
-1
Holders Change %
-20%
% of All Funds
0.1%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
1
Increased
Reduced
1
Closed
2
Calls
Puts
Net Calls
Net Calls Change

Top Buyers

No buyers this quarter
Name Holding Trade Value Shares
Change
Change in
Stake
DCM
1
DAFNA Capital Management
California
$892K
GC
2
GMT Capital
Georgia
$82K -$583 -900 -0.7%
EHC
3
Everett Harris & Co
California
$8K
PCM
4
Perkins Capital Management
Minnesota
-$20K -23,000 Closed

STXS Hedge Fund Activity: Q4 2016 in Review

4 of the 4,000 institutional investors tracked by Wall St. Rank reported a position in Stereotaxis (STXS) for Q4 2016, worth a combined $982K — down 26% from $1.34M a quarter earlier.

Sellers outnumbered buyers: 2 funds closed out of STXS and 1 opened new positions — a net loss of 1 holder — while 1 trimmed existing stakes and 0 added.

The largest seller was Perkins Capital Management, exiting entirely with an estimated $20K sold.

  • 4 institutional investors held Stereotaxis (STXS) as of Q4 2016, down from 5 in Q3 2016.
  • Funds reported $982K of Stereotaxis stock for Q4 2016, down 26% quarter-over-quarter.
  • 1 fund opened new Stereotaxis positions in Q4 2016 and 2 closed out, a net change of -1 holder.
  • The largest Stereotaxis seller in Q4 2016 was Perkins Capital Management, an estimated $20K sold.

Based on aggregated 13F filings for Q4 2016.